Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$3.28 - $4.81 $634,791 - $930,898
-193,534 Reduced 9.65%
1,812,970 $6.27 Million
Q4 2022

Feb 13, 2023

SELL
$3.65 - $4.82 $352,871 - $465,983
-96,677 Reduced 4.6%
2,006,504 $8.99 Million
Q3 2022

Nov 10, 2022

BUY
$2.66 - $3.97 $970,751 - $1.45 Million
364,944 Added 21.0%
2,103,181 $7.66 Million
Q2 2022

Aug 03, 2022

BUY
$2.42 - $4.05 $968 - $1,620
400 Added 0.02%
1,738,237 $4.94 Million
Q1 2022

May 13, 2022

SELL
$3.45 - $5.83 $386,544 - $653,204
-112,042 Reduced 6.06%
1,737,837 $6.81 Million
Q4 2021

Feb 10, 2022

BUY
$4.89 - $7.59 $2.98 Million - $4.63 Million
609,987 Added 49.2%
1,849,879 $10.2 Million
Q2 2021

Jul 20, 2021

BUY
$3.94 - $6.75 $1.49 Million - $2.56 Million
378,930 Added 44.01%
1,239,892 $8.18 Million
Q1 2021

Apr 29, 2021

BUY
$4.03 - $7.25 $36 - $65
9 Added 0.0%
860,962 $3.16 Million
Q4 2020

Jan 22, 2021

SELL
$2.78 - $4.5 $57,690 - $93,384
-20,752 Reduced 2.35%
860,953 $3.29 Million
Q3 2020

Oct 19, 2020

SELL
$2.12 - $3.53 $71,865 - $119,663
-33,899 Reduced 3.7%
881,705 $3.09 Million
Q2 2020

Jul 23, 2020

BUY
$1.66 - $2.73 $484,391 - $796,619
291,802 Added 46.78%
915,604 $2.05 Million
Q1 2020

May 26, 2020

BUY
$1.35 - $4.05 $160 - $481
119 Added 0.02%
623,802 $2.57 Million
Q4 2019

Jan 21, 2020

BUY
$2.3 - $4.6 $1.01 Million - $2.02 Million
438,326 Added 236.48%
623,683 $3,000
Q3 2019

Oct 21, 2019

BUY
$2.9 - $9.56 $287,100 - $946,440
99,000 Added 114.64%
185,357 $1,000
Q2 2019

Aug 01, 2019

SELL
$6.7 - $9.13 $311,550 - $424,545
-46,500 Reduced 35.0%
86,357 $757,000
Q1 2019

May 02, 2019

BUY
$5.7 - $8.73 $699,247 - $1.07 Million
122,675 Added 1204.82%
132,857 $982,000
Q4 2018

Feb 14, 2019

BUY
$5.04 - $10.28 $51,317 - $104,670
10,182 New
10,182 $62,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.